SEC Company Response from CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487) (CLGN) — Apr 18, 2019
CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487)
Date: April 18, 2019 · CIK: 0001631487 · Accession: 0001213900-19-006682
AI Filing Summary & Sentiment
File numbers found in text: 333-228054
Show Raw Text
CORRESP
1
filename1.htm
CollPlant Holdings Ltd.
4 Oppenheimer, Weizmann
Science Park
Rehovot 7670104, Israel
April 18, 2019
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
CollPlant Holdings Ltd.
Registration Statement on Form F-3
File No. 333- 228054
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, CollPlant Holdings Ltd. (the “Company”) hereby respectfully requests that the
effectiveness of the Registration Statement on Form F-3 (File No. 333-228054) of the Company (the “Registration Statement”)
be accelerated so that the Company’s Registration Statement will become effective at 4:30 p.m., Eastern Time, on April 19,
2019 or as soon thereafter as may be practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will
& Emery LLP, by calling Gary Emmanuel at (917) 297-4545. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.
Very truly yours,
COLLPLANT HOLDINGS LTD.
By:
/s/ Eran Rotem
Name:
Eran Rotem
Title:
Deputy CEO and Chief Financial Officer
cc: Gary Emmanuel (McDermott Will & Emery LLP)